Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07510438

AVS Pulse Intravascular Lithotripsy™ (Pulse IVL™) to Open Vessels With Calcific Walls and Enhance Vascular Compliance and Remodeling for Coronary Artery Disease

AVS Pulse Intravascular Lithotripsy™ (Pulse IVL™) to Open Vessels With Calcific Walls and Enhance Vascular Compliance and Remodeling for Coronary Artery Disease - A First-in-Human (FIH) Study

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
15 (estimated)
Sponsor
Amplitude Vascular Systems, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A prospective, open-label, multi-site, FIH with up to fifteen (n=15) patients to assess the safety and preliminary effectiveness of the AVS Pulse Intravascular Lithotripsy™ System (Pulse IVL™ System) when used for the treatment of coronary artery disease.

Conditions

Interventions

TypeNameDescription
DEVICEPulse Intravascular Lithotripsy (Pulse IVL)The Pulse Intravascular Lithotripsy (Pulse IVL) System is used for the treatment of severely calcified stenotic de novo coronary arteries prior to stenting in patients with coronary artery disease.

Timeline

Start date
2026-04-01
Primary completion
2026-12-01
Completion
2027-12-01
First posted
2026-04-03
Last updated
2026-04-03

Source: ClinicalTrials.gov record NCT07510438. Inclusion in this directory is not an endorsement.